BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19549593)

  • 21. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor.
    Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY
    Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis.
    Suzuki H; Willingham MC; Cheng SY
    Thyroid; 2002 Nov; 12(11):963-9. PubMed ID: 12490073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma.
    Lu C; Zhu X; Willingham MC; Cheng SY
    Oncogene; 2012 Apr; 31(16):2007-16. PubMed ID: 21909131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice.
    Kaneshige M; Suzuki H; Kaneshige K; Cheng J; Wimbrow H; Barlow C; Willingham MC; Cheng S
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15095-100. PubMed ID: 11734632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice.
    Zimonjic DB; Kato Y; Ying H; Popescu NC; Cheng SY
    Cancer Genet Cytogenet; 2005 Sep; 161(2):104-9. PubMed ID: 16102579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid hormone receptor mutations in cancer.
    Cheng SY
    Mol Cell Endocrinol; 2003 Dec; 213(1):23-30. PubMed ID: 15062571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant thyroid hormone receptor beta represses the expression and transcriptional activity of peroxisome proliferator-activated receptor gamma during thyroid carcinogenesis.
    Ying H; Suzuki H; Zhao L; Willingham MC; Meltzer P; Cheng SY
    Cancer Res; 2003 Sep; 63(17):5274-80. PubMed ID: 14500358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone.
    O'Shea PJ; Harvey CB; Suzuki H; Kaneshige M; Kaneshige K; Cheng SY; Williams GR
    Mol Endocrinol; 2003 Jul; 17(7):1410-24. PubMed ID: 12677005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma.
    Kim CS; Vasko VV; Kato Y; Kruhlak M; Saji M; Cheng SY; Ringel MD
    Endocrinology; 2005 Oct; 146(10):4456-63. PubMed ID: 16002527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors.
    Guigon CJ; Kim DW; Willingham MC; Cheng SY
    Oncogene; 2011 Jul; 30(30):3381-90. PubMed ID: 21399657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential recruitment of nuclear coregulators directs the isoform-dependent action of mutant thyroid hormone receptors.
    Fozzatti L; Lu C; Kim DW; Cheng SY
    Mol Endocrinol; 2011 Jun; 25(6):908-21. PubMed ID: 21474540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid hormone receptor mutations and disease: insights from knock-in mouse models.
    Cheng SY
    Expert Rev Endocrinol Metab; 2007 Jan; 2(1):47-57. PubMed ID: 30743748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogenic mutations of thyroid hormone receptor β.
    Park JW; Zhao L; Willingham M; Cheng SY
    Oncotarget; 2015 Apr; 6(10):8115-31. PubMed ID: 25924236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma.
    Kamiya Y; Puzianowska-Kuznicka M; McPhie P; Nauman J; Cheng SY; Nauman A
    Carcinogenesis; 2002 Jan; 23(1):25-33. PubMed ID: 11756220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global expression profiling reveals gain-of-function oncogenic activity of a mutated thyroid hormone receptor in thyroid carcinogenesis.
    Lu C; Mishra A; Zhu YJ; Meltzer P; Cheng SY
    Am J Cancer Res; 2011; 1(2):168-191. PubMed ID: 21547001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of TSH in the spontaneous development of asymmetrical thyroid carcinoma in mice with a targeted mutation in a single allele of the thyroid hormone-β receptor.
    Zhao L; Zhu X; Won Park J; Fozzatti L; Willingham M; Cheng SY
    Endocrinology; 2012 Oct; 153(10):5090-100. PubMed ID: 22919057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid hormone receptors/THR genes in human cancer.
    González-Sancho JM; García V; Bonilla F; Muñoz A
    Cancer Lett; 2003 Mar; 192(2):121-32. PubMed ID: 12668276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms.
    Araki O; Ying H; Zhu XG; Willingham MC; Cheng SY
    Mol Endocrinol; 2009 Mar; 23(3):308-15. PubMed ID: 19131509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model.
    Zhu X; Kim DW; Zhao L; Willingham MC; Cheng SY
    Endocr Relat Cancer; 2016 Jul; 23(7):521-33. PubMed ID: 27267120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
    Harrus D; Déméné H; Vasquez E; Boulahtouf A; Germain P; Figueira AC; Privalsky ML; Bourguet W; le Maire A
    Thyroid; 2018 Dec; 28(12):1708-1722. PubMed ID: 30235988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.